Literature DB >> 19780688

Experiences of telemedicine-aided hypertension control in the follow-up of Finnish hypertensive patients.

Juha Varis1, Sampo Karjalainen, Krista Korhonen, Margus Viigimaa, Kristjan Port, Ilkka Kantola.   

Abstract

The prevalence of hypertension is high in Finland. Only one fourth of the drug-treated hypertensive patients reach their target pressure. We evaluated a commercially available telemedicine system for impact in reaching better blood pressure control among Finnish hypertensive patients. A telemedicine system, the Doc@home, was used to assist blood pressure treatment in 19 Finnish hypertensive patients. Blood pressure control improved during the 3-month follow-up. Patient-to-Doc@home compliance was good, but study physicians found the system time consuming in the beginning. According to our results, the Doc@home telemedicine system showed a promising approach in hypertension treatment but needs some further development and trained staff to become a still more practical alternative.

Entities:  

Mesh:

Year:  2009        PMID: 19780688     DOI: 10.1089/tmj.2009.0029

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  3 in total

1.  Medication adherence: a review of pharmacy education, research, practice and policy in Finland.

Authors:  J Simon Bell; Hannes Enlund; Kirsti Vainio
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

2.  Using Information and Communication Technology in Home Care for Communication between Patients, Family Members, and Healthcare Professionals: A Systematic Review.

Authors:  Birgitta Lindberg; Carina Nilsson; Daniel Zotterman; Siv Söderberg; Lisa Skär
Journal:  Int J Telemed Appl       Date:  2013-04-10

3.  Provider- and Patient-Related Barriers to and Facilitators of Digital Health Technology Adoption for Hypertension Management: Scoping Review.

Authors:  Ramya Sita Palacholla; Nils Fischer; Amanda Coleman; Stephen Agboola; Katherine Kirley; Jennifer Felsted; Chelsea Katz; Stacy Lloyd; Kamal Jethwani
Journal:  JMIR Cardio       Date:  2019-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.